How augmented clinical trials are accelerating a vaccine for tuberculosis
Tuberculosis is an endemic infectious disease that affects many of the world's poorest populations. By using the latest techniques in mathematical modelling, augmented clinical trials could help researchers develop an affordable vaccine.